4 drug(s) with this reaction
4,986 total reports
Injection Site Pain has been reported as an adverse reaction across 4 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 4,986 adverse event reports mention injection site pain in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with injection site pain, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have injection site pain listed in their FDA adverse event reports, sorted by report count:
In addition to injection site pain, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
4 drug(s) manufactured by Amgen Inc have injection site pain listed in their FDA adverse event reports: ERENUMAB-AOOE, DENOSUMAB, ROMOSOZUMAB-AQQG, PEGFILGRASTIM.
There are a combined 4,986 reports of injection site pain across 4 Amgen Inc drug(s) in the FDA adverse event database.